Oncogenic KRAS represses the dependence receptor UNC5C via ERK2-FOS signaling in non-small cell lung cancer
Deyu Wang, Man Xiao, Kaicheng Zhou, Peng Yang, Xiting Huang, Runze Miao, Jiajun Fan, Xuyao Zhang, Shaofei Wang · 2026
Read Oncogenic KRAS represses the dependence receptor UNC5C via ERK2-FOS signaling in non-small cell lung cancer by Deyu Wang, Man Xiao, Kaicheng Zhou, Peng Yang, Xiting Huang, Runze Miao, Jiajun Fan, Xuyao Zhang, Shaofei Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13444284.txt.
Description
Deyu Wang and colleagues show how mutant KRAS silences a guard receptor in lung cancer in a 2026 study. KRAS faults drive many non-small cell lung cancers, and the receptor UNC5C can force cancer cells to die when its partner is absent. Why UNC5C vanishes in tumors stayed unclear.
Mutant KRAS pressed UNC5C down in their cell work, and blocking KRAS let it rise again. The press ran through the RAF-MEK-ERK chain, not the twin PI3K path. Within that chain, ERK2 did the work while ERK1 sat out. A factor named FOS, lit by the chain, bound the UNC5C control zone and hushed it. UNC5C fell hardest among its receptor kin in lung tumors and acted as a true guard in tests.
Catalog record
| CREATOR | Deyu Wang, Man Xiao, Kaicheng Zhou, Peng Yang, Xiting Huang, Runze Miao, Jiajun Fan, Xuyao Zhang, Shaofei Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 80471 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |